Last reviewed · How we verify

NCT04195672: NIPE

NIPE as an Indicator of Pain in Sedated/Ventilated Patient Under 3 Years-old Hospitalized in Intensive Care Unit

Completed Last updated 12 December 2019
What this trial tests

trial testing NIPE (MDoloris®) and CBS values in Ventilator Lung; Newborn in 32 participants. Completed in 30 April 2019.

Timeline
1 November 2017
Primary endpoint
25 April 2019
30 April 2019

Quick facts

Lead sponsorUniversity Hospital, Lille
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date1 November 2017
Primary completion25 April 2019
Estimated completion30 April 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Lille

Who can join

Under 3, any sex, with Ventilator Lung; Newborn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective is to assess correlation between Newborn Infant Parasympathetic Index values and external evaluation by Comfort Behaviour Scale during painful medical cares in sedated intubated children admitted in pediatric intensive care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ventilator Lung; Newborn

Currently open trials in the same condition.

Other University Hospital, Lille trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04195672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing